SFI
LYEL icon

Susquehanna Fundamental Investments’s Lyell Immunopharma LYEL Stock Holding History

Susquehanna Fundamental Investments’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$186K Buy
6,410
+2,122
+49% +$101K ﹤0.01% 855
2024
Q1 		$191K Buy
+4,288
New +$184K 0.01% 625

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WA
WuXi AppTec Shanghai, China $19M AUM 20.22% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna Fundamental Investments's LYEL Position: Q2 2024 in Review

Susquehanna Fundamental Investments increased its Lyell Immunopharma (LYEL) stake by 49% in Q2 2024, buying an estimated $101K and bringing the position to 6,410 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #855.

Susquehanna Fundamental Investments first reported a position in LYEL in Q1 2024 and has held it in 2 quarters since. The position peaked at $191K in Q1 2024. 119 funds tracked by Wall St. Rank hold LYEL as of Q2 2024.

  • Susquehanna Fundamental Investments held 6,410 shares of Lyell Immunopharma worth $186K as of Q2 2024.
  • Susquehanna Fundamental Investments bought 2,122 Lyell Immunopharma shares in Q2 2024, an estimated $101K.
  • Lyell Immunopharma made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q2 2024, its #855 holding.
  • Susquehanna Fundamental Investments first reported a position in Lyell Immunopharma in Q1 2024 and has held it in 2 quarters since.
  • Susquehanna Fundamental Investments's Lyell Immunopharma position peaked at $191K in Q1 2024.
  • 119 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q2 2024.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2024, filed 15 Aug 2024.